04/25/2024 4:20 PM | Voyager Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024 4:20 PM | Voyager Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024 4:22 PM | Voyager Therapeutics (Filer)
| Form ARS | |
04/02/2024 2:24 PM | Sandrock Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024 2:29 PM | Swartz Robin (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 4:24 PM | Ferguson Toby (Reporting) Voyager Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/26/2024 4:27 PM | Ferguson Toby (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/13/2024 6:03 AM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 3:00 PM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 3:30 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:32 PM | PFREUNDSCHUH PETER P. (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 3:34 PM | Sandrock Alfred (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 2:13 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 2:16 PM | Swartz Robin (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 2:18 PM | PFREUNDSCHUH PETER P. (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 2:20 PM | Sandrock Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 2:11 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 1:35 PM | ARMISTICE CAPITAL, LLC (Filed by) Voyager Therapeutics (Subject)
| Form SC 13G/A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Voyager Therapeutics (Subject)
| Form SC 13G | |
01/19/2024 3:32 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:34 PM | Swartz Robin (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:20 PM | Voyager Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
01/17/2024 2:21 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024 2:33 PM | Swartz Robin (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:49 PM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 4:20 PM | Voyager Therapeutics (Filer)
| Form 424B5 | |
01/02/2024 6:05 AM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 6:04 AM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 3:41 PM | PFREUNDSCHUH PETER P. (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 3:24 PM | Fahey Sandell Jacquelyn (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:44 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2023 12:57 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2023 3:18 PM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 6:00 AM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/03/2023 6:15 AM | Voyager Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023 3:46 PM | Fahey Sandell Jacquelyn (Reporting) Voyager Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/11/2023 3:46 PM | Fahey Sandell Jacquelyn (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 3:42 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2023 7:04 AM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/06/2023 10:45 AM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023 3:32 PM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Issuer) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Department of Defense Has a New Drone Contractor (Ad) The Department of Defense just granted a major advantage to a small UAV provider.
Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes. Click here to see how to invest |
06/30/2023 9:31 AM | Carter Todd Alfred (Reporting) Voyager Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 3:37 PM | Colon Grace (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:38 PM | Higgins Michael J (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:39 PM | Onyia Jude (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:40 PM | Vitale Nancy (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:40 PM | MACKEY CATHERINE J (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:41 PM | PIERCE GLENN (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:30 PM | Voyager Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2023 3:34 PM | Hyman Steven (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:35 PM | SCANGOS GEORGE A (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 3:36 PM | GERAGHTY JAMES A (Reporting) Voyager Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |